Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Calabrese

Showing results (251-260 of 316) with videos related to

Pageof 32
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2004
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser aloneMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Affective Disorders|September 8, 2014
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorderLouisa G Sylvia, Dustin J Rabideau, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
Clinical Trials (London, England)|May 30, 2014
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trialDustin J Rabideau, Andrew A Nierenberg, Louisa G Sylvia, et al.
Journal of Affective Disorders|July 13, 2019
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictorsVicki C Fung, Lindsay N Overhage, Louisa G Sylvia, et al.
The Australian and New Zealand Journal of Psychiatry|November 17, 2017
Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depressionMarco Antonio Caldieraro, Samantha Walsh, Thilo Deckersbach, et al.
Psychiatric Services (Washington, D.C.)|August 16, 2013
Use of treatment services in a comparative effectiveness study of bipolar disorderLouisa G Sylvia, Dan Iosifescu, Edward S Friedman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2003
Maintenance efficacy of divalproex in the prevention of bipolar depressionLaszlo Gyulai, Charles L Bowden, Susan L McElroy, et al.
Clinical Trials (London, England)|November 15, 2011
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorderLouisa G Sylvia, Noreen A Reilly-Harrington, Andrew C Leon, et al.
Journal of Psychiatric Research|August 6, 2013
The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness researchNoreen A Reilly-Harrington, Louisa G Sylvia, Andrew C Leon, et al.
Pageof 32

Showing results (251-260 of 316) with videos related to

Sort By:
Pageof 32
The British Journal of Psychiatry : the Journal of Mental Science|April 2, 2004
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser aloneMauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Journal of Affective Disorders|September 8, 2014
The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorderLouisa G Sylvia, Dustin J Rabideau, Andrew A Nierenberg, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
Clinical Trials (London, England)|May 30, 2014
A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trialDustin J Rabideau, Andrew A Nierenberg, Louisa G Sylvia, et al.
Journal of Affective Disorders|July 13, 2019
Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictorsVicki C Fung, Lindsay N Overhage, Louisa G Sylvia, et al.
The Australian and New Zealand Journal of Psychiatry|November 17, 2017
Decreased activation and subsyndromal manic symptoms predict lower remission rates in bipolar depressionMarco Antonio Caldieraro, Samantha Walsh, Thilo Deckersbach, et al.
Psychiatric Services (Washington, D.C.)|August 16, 2013
Use of treatment services in a comparative effectiveness study of bipolar disorderLouisa G Sylvia, Dan Iosifescu, Edward S Friedman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2003
Maintenance efficacy of divalproex in the prevention of bipolar depressionLaszlo Gyulai, Charles L Bowden, Susan L McElroy, et al.
Clinical Trials (London, England)|November 15, 2011
Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorderLouisa G Sylvia, Noreen A Reilly-Harrington, Andrew C Leon, et al.
Journal of Psychiatric Research|August 6, 2013
The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness researchNoreen A Reilly-Harrington, Louisa G Sylvia, Andrew C Leon, et al.
Pageof 32